Answers are grounded in this paper and cite their sources.
With the emergence of novel drugs, ameliorated chemotherapy, molecular targeted therapy and hematopoietic stem cell transplant, complete remission (CR) rates for acute myelogenous leukemia (AML) ha...
No takes yet. Share an insight, caveat, or question.
Chen et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: